These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12203803)

  • 21. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?
    Guney K; Yoldas B; Ozbilim G; Derin AT; Sarihan S; Balkan E
    Saudi Med J; 2007 Feb; 28(2):216-20. PubMed ID: 17268699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
    Gourin CG; Zhi W; Adam BL
    Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
    Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
    Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma.
    Deng YF; Chen P; Lin YZ; Le JZ; Wu XL; Yu MQ; Zhuang PY; Gao MH
    J Laryngol Otol; 2003 Mar; 117(3):190-4. PubMed ID: 12648374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Christiansen H; Hermann RM; Martin A; Florez R; Kahler E; Nitsche M; Hille A; Steiner W; Hess CF; Pradier O
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1067-74. PubMed ID: 16750331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma.
    Oude Ophuis MB; Mulder TP; Peters WH; Manni JJ
    Cancer; 1998 Jun; 82(12):2434-8. PubMed ID: 9635537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.
    Dinshaw KA; Agarwal JP; Laskar SG; Gupta T; Shrivastava SK; Cruz AD
    J Surg Oncol; 2005 Jul; 91(1):48-55. PubMed ID: 15999358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases.
    Salzman R; Kanková K; Pácal L; Tomandl J; Horáková Z; Kostrica R
    Neoplasma; 2007; 54(4):321-5. PubMed ID: 17822322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.
    Li X; Di B; Shang Y; Zhou Y; Cheng J; He Z
    Eur J Surg Oncol; 2009 Dec; 35(12):1348-53. PubMed ID: 19616915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
    Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
    Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
    Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
    Brunner M; Thurnher D; Heiduschka G; Grasl MCh; Brostjan C; Erovic BM
    J Surg Oncol; 2008 Dec; 98(7):545-50. PubMed ID: 18792958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy.
    van de Pol SM; Doornaert PA; de Bree R; Leemans CR; Slotman BJ; Langendijk JA
    Oral Oncol; 2006 Feb; 42(2):131-8. PubMed ID: 16146705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users.
    Gillespie MB; Moody MW; Lee FS; Poole LJ; Hornig JD; Lathers D; Young MR; Day TA
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):28-31. PubMed ID: 17224518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.